Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.91
|
2.962
|
2.948
|
2.948
|
2.948
|
2.948
|
|
|
|
|
2.986
|
3.038
|
3.072
|
2.996
|
3.072
|
2.996
|
|
|
6.02
|
3.00
|
3.078
|
3.13
|
3.104
|
3.104
|
3.104
|
3.104
|
|
|
|
|
3.104
|
3.156
|
3.004
|
3.004
|
3.076
|
3.076
|
|
|
922.80
|
2.00
|
3.012
|
3.06
|
2.982
|
2.982
|
3.052
|
3.042
|
|
|
989.90
|
3.00
|
2.974
|
3.022
|
3.192
|
3.068
|
3.192
|
3.068
|
|
|
306.80
|
2.00
|
|
|
3.188
|
3.188
|
3.188
|
3.188
|
|
|
|
|
3.20
|
3.25
|
3.382
|
3.382
|
3.382
|
3.382
|
|
|
|
|
3.334
|
3.426
|
3.426
|
3.426
|
3.426
|
3.426
|
|
|
|
|
3.392
|
3.486
|
3.392
|
3.392
|
3.454
|
3.454
|
|
|
345.40
|
2.00
|
Tempest Therapeutics Inc. operates as a development-stage biotechnology company. The Company focuses on targeted and immune-eediated cancer therapies that modulate anti-tumor immunity pathways. Tempest Therapeutics serves customers worldwide.